维普中文期刊产品整合服务
132篇 您的检索式:作者名="Distefano G"
    题名 作者 年代 出处 被引量
1Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin,paclitaxel and cisplatin显示文摘D'Agostino G Distefano M Greggi S 2002Cancer Chemother Pharmacol2002,49,3:1
2Histological and molecular analysis of pollerrpistil interaction in demenfine显示文摘DISTEFANO G CARUSO M LA MALFA S 2009Plant Cell Reports2009,28,9:1
3Increased cyelooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients显示文摘Ferrandina G Lauriola L Distefano MG 0,,:1
4Cellular distribution of GAP-43mRNA in hippocampus and cerebellum of adult rat brain by in situ RT-PCR 显示文摘Casoli T DiStefano G 2001Histochem Cytochem2001,49,9:1
5Evaluation of transdermal theophylline pharmacokinetics in neonates显示文摘Micali G Bhatt RH Distefano G 1993Pharmacotherapy1993,13,4:1
6Synergistic antiproliferative activity of tamoxifen and docetaxed on three oestrogen receptomegaive cancer cell Lines is mediated by induction of apoptosis显示文摘Ferlini C Scambia G Distefano M 1997Br J Cancer1997,75,:1
7Animia in patients with locally advanced cervical carcinoma adminisitered preoperative radiochemotherapy association with pathological response to treatment and clinical outcome 显示文摘Ferrandina G Distefano M Smaniotto D 2006Gynecol Oncol2006,103,5:1
8Ouality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative ehemoradiotherapy 显示文摘Distefano M Riccardi S Capelli G 2008Gyneeol Oneol2008,111,1:1
9Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients 显示文摘Fetrandina G Lauriola L Distefano MG 2002J Clin Oncol2002,20,:1
10Paclitaxel, epirubicin, andcisplatin(TEP) regimen as neoadjuvant treat- ment in locally advanced cervical cancer:Long-term results显示文摘Ferrandina G Distefano M G De Vincenzo R 2013Gynecol Oncol2013,128,3:1
11Incresed cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients显示文摘Ferrandian G Lauriola L Distefano MG 2002J Clin Oncol2002,20,4:1
12Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis显示文摘Ferlini C Scambia G Distefano M 1997Br J Cancer1997,75,6:1
13Quality of life and psycholog- ical distress in locally advanced cervical cancer patients administered pre - operative chemoradiotherapy 显示文摘Distefano M Riccardi S Capelli G 2008Gynecologic Oncology2008,,1:1
14A new Chinese hamster ovary cell line expressing alpha 2, 6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins显示文摘 Distefano G Buckberry L D 2000Biochim Biophys Acta2000,1474,3:1
15Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, pa- clitaxel and cisplatin 显示文摘D'Agostino G Distefano M Greggi S 2002Cancer Chemother Pharmacol2002,49,3:1
16Increasedcyclooxygenase-2 expression is associated With chemotherapy resistance and poor survival in cervical cancer patients显示文摘Ferrandina G Lauriola L Distefano M G 2002Clin Oncol2002,20,4:1
17Synergistic antiproliferative activity of tamoxifen and docetaxed on three oestrogen receptornegative cancer cell lines is mediated by the induction of apoptosis 显示文摘 Scambia G Distefano M 1997Br J Cancer1997,75,:1
18Management of an adva-nced ovarian cancer at 15 wceks of gestation:Case report and literature review显示文摘 Distefano M Testa A 2005Gynecologic Oncology2005,97,:1
19Increased Cylooxygenase-2(COX-2) expression is associated with chemoth-erapy resistance and poor survival in cervical cancer patients显示文摘Ferrandina G Lauriola L Distefano MG 2002J Clin Oncol2002,20,4:1
20Epidermal growth Fetor receptor (EGFR) is not related to the prognosis of cervical cancer显示文摘Scambia G Ferrandina G Distefano Mv 1998Cancer Lett1998,123,2:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费